ATE482398T1 - Verfahren zur stratifizierung von herzinsuffizienz - Google Patents
Verfahren zur stratifizierung von herzinsuffizienzInfo
- Publication number
- ATE482398T1 ATE482398T1 AT06754992T AT06754992T ATE482398T1 AT E482398 T1 ATE482398 T1 AT E482398T1 AT 06754992 T AT06754992 T AT 06754992T AT 06754992 T AT06754992 T AT 06754992T AT E482398 T1 ATE482398 T1 AT E482398T1
- Authority
- AT
- Austria
- Prior art keywords
- heart failure
- stratification
- preprobnp
- devices
- amount
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 206010019280 Heart failures Diseases 0.000 title 1
- 238000013517 stratification Methods 0.000 title 1
- 102100036836 Natriuretic peptides B Human genes 0.000 abstract 2
- 101710187802 Natriuretic peptides B Proteins 0.000 abstract 2
- 208000019267 mild heart failure Diseases 0.000 abstract 2
- 208000019266 moderate heart failure Diseases 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 210000002700 urine Anatomy 0.000 abstract 2
- 230000007211 cardiovascular event Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Electrotherapy Devices (AREA)
- External Artificial Organs (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05010043A EP1722232A1 (de) | 2005-05-09 | 2005-05-09 | Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion |
| PCT/EP2006/062031 WO2006120152A1 (en) | 2005-05-09 | 2006-05-03 | Devices and methods for diagnosing or predicting early stage cardiac dysfunctions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE482398T1 true ATE482398T1 (de) | 2010-10-15 |
Family
ID=34936290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06754992T ATE482398T1 (de) | 2005-05-09 | 2006-05-03 | Verfahren zur stratifizierung von herzinsuffizienz |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20110104813A1 (de) |
| EP (2) | EP1722232A1 (de) |
| JP (1) | JP4927825B2 (de) |
| CN (2) | CN103091497A (de) |
| AT (1) | ATE482398T1 (de) |
| CA (1) | CA2605247A1 (de) |
| DE (1) | DE602006017058D1 (de) |
| ES (1) | ES2352351T3 (de) |
| WO (1) | WO2006120152A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1722232A1 (de) * | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion |
| JP2010517023A (ja) * | 2007-01-25 | 2010-05-20 | エフ．ホフマン−ラ ロシュ アーゲー | 心不全の評価におけるｉｇｆｂｐ−７の使用 |
| SG175821A1 (en) | 2009-04-29 | 2011-12-29 | Academisch Medisch Ct Bij De Univeriteit Van Amsterdam | Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure |
| CN103370619B (zh) * | 2010-11-29 | 2016-01-20 | 美艾利尔圣地亚哥有限公司 | 诊断或风险预测心力衰竭的方法和试剂 |
| WO2014023820A1 (en) | 2012-08-09 | 2014-02-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Diagnostic of heart failure |
| SG11201702490PA (en) * | 2014-10-10 | 2017-04-27 | Akira Matsumori | Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure |
| US11193947B2 (en) | 2016-06-03 | 2021-12-07 | Cedars-Sinai Medical Center | B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment |
| WO2017210488A1 (en) * | 2016-06-03 | 2017-12-07 | Cedars-Sinai Medical Center | B-type natriuretic peptide proteolytic assay for cardiovascular disease risk assessment |
| US20190257842A1 (en) * | 2016-08-09 | 2019-08-22 | Otsuka Pharmaceutical Co., Ltd. | Method for assisting diagnosis of alzheimer's disease using urine biomarker |
| EP3665483A4 (de) * | 2017-08-08 | 2021-07-14 | Queensland University of Technology | Verfahren zur diagnose von herzversagen im anfangsstadium |
| US11255844B2 (en) * | 2018-03-06 | 2022-02-22 | Fresenius Medical Care Holdings, Inc. | Peritoneal dialysis systems and related methods |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| JP2676114B2 (ja) * | 1990-04-16 | 1997-11-12 | 塩野義製薬株式会社 | ｈＢＮＰを認識するモノクローナル抗体および該抗体を用いるｈＢＮＰの免疫測定法 |
| PL204235B1 (pl) * | 1999-01-29 | 2009-12-31 | Roche Diagnostics Gmbh | Sposób wykrywania natywnego N-końcowego proBNP, zastosowanie tego sposobu, zastosowanie zrekombinowanego N-końcowego proBNP, przeciwciała przeciw zrekombinowanemu N-końcowemu proBNP, linie komórkowe i sposoby wytwarzania przeciwciał poliklonalnych i monoklonalnych |
| US7632647B2 (en) * | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| AUPS169202A0 (en) * | 2002-04-11 | 2002-05-16 | Goetze, Jens Peter | Neuropeptide assay |
| MXPA03004105A (es) * | 2002-05-14 | 2004-10-15 | Hoffmann La Roche | Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores. |
| GB0216191D0 (en) * | 2002-07-11 | 2002-08-21 | Univ Leicester | Plasma urotensin in human heart failure |
| US8263325B2 (en) * | 2002-11-15 | 2012-09-11 | Ottawa Heart Institute Research Corporation | Predicting, detecting and monitoring treatment of cardiomyopathies and myocarditis |
| US7109023B2 (en) * | 2002-11-18 | 2006-09-19 | Princeton Biomeditech Corporation | Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients |
| WO2004046729A2 (en) * | 2002-11-21 | 2004-06-03 | The University Of Leicester | Bodily fluid markers of tissue hypoxia |
| US7092759B2 (en) * | 2003-07-30 | 2006-08-15 | Medtronic, Inc. | Method of optimizing cardiac resynchronization therapy using sensor signals of septal wall motion |
| US7887750B2 (en) * | 2004-05-05 | 2011-02-15 | Bayer Healthcare Llc | Analytical systems, devices, and cartridges therefor |
| EP1722232A1 (de) * | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion |
-
2005
- 2005-05-09 EP EP05010043A patent/EP1722232A1/de not_active Withdrawn
-
2006
- 2006-05-03 DE DE602006017058T patent/DE602006017058D1/de active Active
- 2006-05-03 EP EP06754992A patent/EP1880221B1/de active Active
- 2006-05-03 CN CN2013100056784A patent/CN103091497A/zh active Pending
- 2006-05-03 ES ES06754992T patent/ES2352351T3/es active Active
- 2006-05-03 AT AT06754992T patent/ATE482398T1/de active
- 2006-05-03 CA CA002605247A patent/CA2605247A1/en not_active Abandoned
- 2006-05-03 WO PCT/EP2006/062031 patent/WO2006120152A1/en not_active Ceased
- 2006-05-03 CN CN2006800158682A patent/CN101171517B/zh active Active
- 2006-05-03 JP JP2008510547A patent/JP4927825B2/ja active Active
-
2007
- 2007-11-07 US US11/936,169 patent/US20110104813A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008541078A (ja) | 2008-11-20 |
| CN103091497A (zh) | 2013-05-08 |
| CN101171517B (zh) | 2013-10-09 |
| CN101171517A (zh) | 2008-04-30 |
| EP1880221B1 (de) | 2010-09-22 |
| HK1119771A1 (en) | 2009-03-13 |
| US20110104813A1 (en) | 2011-05-05 |
| ES2352351T3 (es) | 2011-02-17 |
| JP4927825B2 (ja) | 2012-05-09 |
| EP1880221A1 (de) | 2008-01-23 |
| CA2605247A1 (en) | 2006-11-16 |
| EP1722232A1 (de) | 2006-11-15 |
| DE602006017058D1 (de) | 2010-11-04 |
| WO2006120152A1 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE511656T1 (de) | Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis | |
| BRPI0410261A (pt) | método de detecção de probnp natural | |
| ATE514950T1 (de) | Verfahren zur untersuchung von sepsis bei menschen | |
| ATE415662T1 (de) | Bestimmung der tatsächlichen zeit, die ein prozessor bei der ausführung eines codeteiles aufwendet | |
| ATE537450T1 (de) | Igfbp2-biomarker | |
| DE602005024639D1 (de) | Verfahren und Gerät zur Diagnose des Ermüdungsversagens von Turboladern | |
| DK1974210T3 (da) | Fremgangsmåde til diagnosticering af polycystisk nyresygdom | |
| ATE482398T1 (de) | Verfahren zur stratifizierung von herzinsuffizienz | |
| DK1316801T3 (da) | Sammensætninger og fremgangsmåder til detektion og behandling af sygdomme og tilstande, som er relateret til kemokinreceptorer | |
| WO2007111938A3 (en) | Inflammation-inhibitory serum factors and uses thereof | |
| DE602006016589D1 (de) | Neue markierungsstrategien für den empfindlichen nachweis von analyten | |
| ATE504002T1 (de) | Erkennung und vorhersage von frühgeburten | |
| ATE519116T1 (de) | Verfahren zur normierung der konzentration von analyten in einer urinprobe | |
| ATE524561T1 (de) | Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken | |
| ATE473448T1 (de) | Verfahren zur diagnose von herz-kreislauf- krankheiten | |
| DE602007010644D1 (de) | Biomarker zur beurteilung der leberfunktion | |
| DE602006008581D1 (de) | Verfahren zur bestimmung von montagebedingungen, vorrichtung zur bestimmung von montagebedingungen und montagevorrichtung | |
| ATE550668T1 (de) | Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis | |
| DE602007004570D1 (de) | Verwendung von Nogo-C bei der Beurteilung von Herzversagen | |
| ATE515574T1 (de) | Verwendung von spla2-aktivität zur diagnose von herz-kreislauf-ereignissen | |
| DE60126991D1 (de) | Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE | |
| EP1767652A4 (de) | Genmarker und dessen verwendung | |
| DE112006000481A5 (de) | Verfahren zur Bestimmung der elastischen Verformung von Bauteilen | |
| DE602005015627D1 (de) | Verfahren zur messung von proinsulin und c-peptid sowie kit dafür | |
| ATE437182T1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1880221 Country of ref document: EP |